1982
DOI: 10.1016/0002-9149(82)91963-4
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
33
0
1

Year Published

1985
1985
2007
2007

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(34 citation statements)
references
References 19 publications
0
33
0
1
Order By: Relevance
“…139 The infusion of GIK was shown to reduce the frequency and duration of ventricular arrhythmias and to improve the survival of patients after myocardial infarction. 140,141 Similarly, beneficial effects on ejection fraction and survival were observed when GIK was administered in conjunction with a thrombolytic agent 142 or when GIK was given to patients with myocardial infarction and non-insulindependent diabetes mellitus. 143 Most recently, a meta-analysis of all placebo-controlled trials of GIK treatment in acute myocardial infarction has shown an overall mortality reduction of 28%.…”
Section: Glucose and Insulin As Substrates For Postischemic Heartmentioning
confidence: 96%
“…139 The infusion of GIK was shown to reduce the frequency and duration of ventricular arrhythmias and to improve the survival of patients after myocardial infarction. 140,141 Similarly, beneficial effects on ejection fraction and survival were observed when GIK was administered in conjunction with a thrombolytic agent 142 or when GIK was given to patients with myocardial infarction and non-insulindependent diabetes mellitus. 143 Most recently, a meta-analysis of all placebo-controlled trials of GIK treatment in acute myocardial infarction has shown an overall mortality reduction of 28%.…”
Section: Glucose and Insulin As Substrates For Postischemic Heartmentioning
confidence: 96%
“…In the 1960s SodiPallares further popularized this treatment initially for arrhythmias, and later for angina (18,19). Glucose-insulin-potassium infusions have been advocated for patients with acute myocardial infarctions by other investigators and have also been administered before cardiac surgery (20)(21)(22)(23)(24)(25)(26)(27). Animal studies have shown that glucose infusions increase ATP levels and glycogen stores, and reduce tissue necrosis during acute infarctions (28)(29)(30).…”
Section: Introductionmentioning
confidence: 99%
“…During ischemia and hypoxia, glycolysis is accelerated and glucose utilization is enhanced (4)(5)(6)(7)(8). Glucose-insulin-potassium infusions have been advocated for patients with acute myocardial infarctions and chronic ischemic heart disease; however, the efficacy of this treatment for limiting myocardial infarct size and left ventricular dysfunction still remains to be determined (3,(9)(10)(11)(12)(13)(14)(15)(16)(17).…”
Section: Introductionmentioning
confidence: 99%